Lung Cancer
Conditions
Keywords
SAMI, Symptom Assessment and Management Intervention Program
Brief summary
The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).
Interventions
BEHAVIORALSAMI
Patients and Health care providers use Symptom Assessment and Management Intervention: patient report symptoms by answering validated questionnaires in a secure online program. The system generates a report for providers that displays symptoms and customized suggestions for their clinical management.
Sponsors
Boston Medical Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* HCPs: attending physician, thoracic medical oncologist, expected to work in the setting for at least 2 years. * Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV non-small cell lung cancer OR limited or extensive stage small cell lung cancer; receiving care in the out-patient setting; receiving treatment with chemotherapy +/- additional therapies; English speaking.
Exclusion criteria
* Patients: Any patient who needs emergent care, routine visits scheduled less than once a month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| % completion of intervention use and adherence to suggested symptom management strategies. | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Health-related quality of life | 6 months |
Countries
United States
Outcome results
None listed